A common belief is that not all alcoholic beverages are equal in their health effects. Red wine, in particular, is often considered a healthier choice due to its high resveratrol content, an antioxidant believed to have anti-inflammatory and cancer-protective properties.
However, researchers from the Brown University School of Public Health have examined this assumption in a recent study published in the journal Nutrients. Their findings challenge the widely held perception that red wine offers significant protection against cancer.
Examining Wine Consumption and Its Association with Cancer and Skin Cancer Risk
In their study, researchers analyzed data from 42 observational studies involving nearly 96,000 participants to compare the cancer risks associated with red and white wine. Led by Eunyoung Cho, an associate professor of epidemiology and dermatology at Brown, the research team found no clear evidence that red wine reduces cancer risk.
Additionally, their findings did not indicate an overall increased cancer risk from wine consumption, regardless of type. This meta-analysis aimed to provide a comprehensive evaluation of the relationship between wine consumption and cancer risk.

While the study found no major difference in overall cancer risk between red and white wine, an important distinction emerged in relation to skin cancer. Specifically, white wine consumption was linked to a 22% increased risk of skin cancer, whereas red wine did not show a similar association.
The exact reasons for this increased risk remain unclear, though researchers suggest that heavy wine consumption may be correlated with high-risk behaviors, such as indoor tanning and poor sunscreen use. However, why white wine, in particular, contributes to higher skin cancer risk is still uncertain.
Gender-Specific Cancer Risks: Investigating White Wine’s Impact on Women’s Health
The study also found a stronger link between white wine consumption and increased overall cancer risk in women. This discovery raises questions about potential biological or lifestyle factors that might contribute to the observed gender differences.
Further research is needed to explore whether certain compounds in white wine could be interacting differently in women’s bodies, leading to a higher susceptibility to cancer. These findings emphasize the importance of studying the specific effects of alcohol consumption across different demographics.
This study is the first comprehensive meta-analysis to directly compare the cancer risks of red and white wine, challenging the notion that red wine is a healthier option. Additionally, the findings highlight the need for further investigation into the association between white wine consumption and cancer risk, particularly in women.
Given that alcohol—specifically ethanol—metabolizes into harmful compounds that damage DNA and proteins, contributing to cancer risk, alcohol consumption remains a significant public health concern. In 2020 alone, excessive alcohol consumption was linked to over 740,000 cancer cases worldwide, underscoring the importance of continued research and awareness regarding alcohol-related health risks.